At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 150 enrolled
Drug / intervention
Atorvastatin 10mg +2 moredrug
Likely dose
Atorvastatin 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia: A Randomized, add-on, Placebo-controlled Clinical Trial
All India Institute of Medical Sciences, Bhubaneswar·interventional·Posted Apr 8, 2019·Updated Apr 6, 2022
In Brief
A Phase 4 clinical trial evaluating Atorvastatin 10mg, Virgin Coconut Oil (VCO), and 1 other intervention for Dyslipidemias. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The present research will help to assess the effect of virgin coconut oil on cholesterol level and also will help to know whether virgin coconut oil can reduce the risk of heart diseases or not.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemias
CountriesIndia
CollaboratorsCoconut Development Board, Government of India
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartMay 2019
Primary CompletionNov 2021
Study CompletionDec 2021
TodayJul 2026
First PostedApr 8, 2019
Enrollment StartMay 22, 2019
Primary CompletionNov 30, 2021
Study CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.2 years ago
Interventions
Atorvastatin 10mgdrug
Atorvastatin 10 mg per day
Virgin Coconut Oil (VCO)dietary
Capsule VCO (1000 mg/day)
Placeboother
Placebo capsule - 1 capsule per day